How big is Verrica Pharmaceuticals, Inc.?

Jun 22 2025 06:09 PM IST
share
Share Via
As of Jun 18, Verrica Pharmaceuticals, Inc. has a market capitalization of 59.40 million and reported net sales of 7.18 million with a net profit of -65.99 million over the latest four quarters. Shareholder's funds are at -9.86 million, and total assets amount to 54.62 million.
As of Jun 18, Verrica Pharmaceuticals, Inc. has a market capitalization of 59.40 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 7.18 million, while the sum of net profit for the same period is -65.99 million.

As of Dec 24, the shareholder's funds are reported at -9.86 million, and the total assets amount to 54.62 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News